Antihypertensive activity

Antihypertensive activity refers to the physiological process or pharmacological effect of reducing elevated blood pressure. It is not a single molecular target, receptor, or enzyme, but rather a therapeutic outcome resulting from the modulation of various biological pathways involved in cardiovascular homeostasis [1][2]. Major systems targeted to achieve this activity include the renin-angiotensin-aldosterone system (RAAS), the sympathetic nervous system, and the renal system, which collectively regulate vascular tone and fluid balance [1]. Clinical agents exhibiting this activity, such as ACE inhibitors, angiotensin II receptor blockers (ARBs), and calcium channel blockers, interact with specific proteins to decrease peripheral resistance or cardiac output [3]. Achieving and maintaining antihypertensive activity is a primary clinical goal in managing hypertension to prevent life-threatening complications, including myocardial infarction, stroke, and end-stage renal disease [2]. Monitoring this activity is standardly performed through the clinical measurement of systolic and diastolic blood pressure [1]. Sources: [1] StatPearls: Antihypertensive Medications (https://www.ncbi.nlm.nih.gov/books/NBK532992/) [2] NIH National Heart, Lung, and Blood Institute: High Blood Pressure (https://www.nhlbi.nih.gov/health/high-blood-pressure) [3] American Heart Association: Types of Blood Pressure Medications (https://www.heart.org/en/health-topics/high-blood-pressure/changes-you-can-make-to-manage-high-blood-pressure/types-of-blood-pressure-medications)

Other names

Blood pressure lowering effectHypotensive activityAntihypertensive effect

Antihypertensive activity is achieved through diverse molecular mechanisms including the inhibition of the renin-angiotensin-aldosterone system (RAAS), the blockade of L-type voltage-gated calcium channels, the antagonism of adrenergic receptors, and the promotion of renal sodium excretion [1][3].